GlassScriptPhysician profile
Albert J Phillips
NPI 1568554723
$1,288.65
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $260 · 2021: $507 · 2022: $251 · 2023: $21.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.50 | 2019-2022 | |
| Davol INC. | $148.40 | 2020 | |
| Therapeuticsmd, INC. | $92.27 | 2019-2022 | |
| Amgen INC. | $69.85 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $62.71 | 2021-2022 | |
| Allergan, INC. | $61.82 | 2019-2020 | |
| Myovant Sciences INC. | $48.12 | 2022 | |
| Agile Therapeutics, INC. | $45.68 | 2021 | |
| Evofem Biosciences, INC. | $42.57 | 2021 | |
| Merck Sharp & Dohme LLC | $36.17 | 2019 | |
| Aspira Women'S Health INC | $31.66 | 2021 | |
| Ascend Therapeutics US, LLC | $26.67 | 2021 | |
| Hologic Sales and Service, LLC | $22.39 | 2022 | |
| Amag Pharmaceuticals, INC. | $22.14 | 2019 | |
| Applied Medical Resources Corporation | $21.05 | 2023 | Gelpoint V-Path |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.84 | 2021 | |
| Organon LLC | $17.56 | 2022 | |
| Scynexis, INC. | $17.14 | 2022 | |
| Alydia Health | $16.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.